Ryvu Therapeutics S.A.
WSE:RVU
55.80
+ zł0.80 (1.45%)
55.80
+ zł0.80 (1.45%)
End-of-day quote: 05/17/2024

Ryvu Therapeutics financials at a glance

The revenue of Ryvu Therapeutics is reported as 0.0673 billion Zlotych in the fiscal year 2023. The earnings were -4.02 Zlotych per share in 2023, which was 12.61 higher than 2022. And about -0.10711 billion Zlotych are reported as free cash flow in the financials of Ryvu Therapeutics 2023. No dividends were paid to the shareholders of the Ryvu Therapeutics stock WSE:RVU in the financial year 2023.

zł67.30M
Revenue
zł-4.02
Earnings Per Share
73.92%
Gross Margin %
zł-,112.00M
Free Cash Flow
Revenue
67.30
Earnings Per Share
-4.02
Gross Margin %
73.92
Free Cash Flow
-,112.00

Financials

Year Year TTM 2023 2022 2021 2020 2018 2017 2016 2015 2014
Rev. Revenue N/A zł67.30M zł68.44M zł37.08M zł36.95M zł110.10M zł105.87M zł60.20M zł55.73M zł41.30M
GM % Gross Margin % 78.93% 73.92% 74.57% 62.99% 76.28% -50.04% 75.41% 79.84% 79.23% 80.70%
OM Operating Margin -87.66% -,144.70% -,103.29% -,210.02% -96.63% -47.10% 12.00% -1.72% 3.81% 12.72%
EPS Earnings Per Share zł-3.36 zł-4.02 zł-4.60 zł-4.22 zł-1.89 zł0.00 zł0.48 zł0.20 zł0.48 zł0.56
Div. Dividends N/A zł0.00 zł0.00 zł0.00 zł0.00 zł0.00 zł0.00 zł0.00 zł0.00 zł0.00
PR % Payout Ratio % 0 0 0 0 0 0 0.00% 0 0.00% 0
Sha. Shares N/AM 23.12M 23.12M 18.36M 18.36M 15.97M 13.77M 13.44M 13.12M 10.46M
OCF Operating Cash Flow N/A zł-,103.50M zł23.50M zł-57.87M zł-10.64M zł-36.42M zł10.98M zł-6.28M zł-16.43M zł0.00M
FCF Free Cash Flow N/A zł-,112.00M zł17.25M zł-69.85M zł-66.58M zł-54.48M zł-10.58M zł-27.49M zł-21.62M zł0.00M
FCFS Free Cash Flow Per Share zł-0.26 zł-4.07 zł0.82 zł-3.81 zł-2.67 zł-2.84 zł-0.77 zł-2.04 zł-1.66 zł-0.81